Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iberia Pharmaceuticals is an Indian pharmaceutical company specializing in dermatology, wellness, and chronic care. The company develops and distributes a diverse portfolio of science-backed skincare products under brands such as KeyCi and maintains strategic partnerships with global dermatological leaders like Sesderma and Mediderma. Through its Metacare division, Iberia also provides therapeutic solutions for chronic conditions including diabetes and cardiovascular disease. The company operates advanced manufacturing and R&D facilities in India, utilizing technologies such as liposomal delivery systems to enhance the efficacy and safety of its formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iberia.